Bsw Wealth Partners Gilead Sciences, Inc. Transaction History

Bsw Wealth Partners

$661 Million
Q3 2024

A detailed history of Bsw Wealth Partners transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bsw Wealth Partners holds 5,713 shares of GILD stock, worth $524,681. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,713

Previous 5,119 11.6%

Holding current value

$524,681

Previous $351,000 36.18%

% of portfolio

0.07%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$66.59 - $83.99 $39,554 - $49,890	594 Added 11.6%	5,713 $478,000
Q2 2024 Jul 16, 2024	BUY	$63.15 - $72.88 $20,460 - $23,613	324 Added 6.76%	5,119 $351,000
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $42,733 - $52,112	-597 Reduced 11.07%	4,795 $351,000
Q4 2023 Jan 25, 2024	SELL	$73.27 - $83.09 $33,191 - $37,639	-453 Reduced 7.75%	5,392 $436,000
Q3 2023 Oct 27, 2023	SELL	$73.94 - $80.67 $34,160 - $37,269	-462 Reduced 7.33%	5,845 $438,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $23,411 - $26,703	-308 Reduced 4.66%	6,307 $486,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $22,883 - $26,071	296 Added 4.68%	6,615 $548,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $52,037 - $74,707	835 Added 15.23%	6,319 $542,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $7,680 - $8,773	129 Added 2.41%	5,484 $338,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $2,077 - $2,340	36 Added 0.68%	5,355 $331,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $133,563 - $167,369	-2,306 Reduced 30.24%	5,319 $316,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $171,153 - $194,262	2,638 Added 52.9%	7,625 $554,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $10,965 - $11,830	162 Added 3.36%	4,987 $348,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $64,422 - $70,390	1,015 Added 26.64%	4,825 $332,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $228,600 - $260,832	3,810 New	3,810 $246,000
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $81,769 - $89,944	-1,327 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $3,250 - $3,588	52 Added 4.08%	1,327 $84,000
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $78,884 - $88,459	1,275 New	1,275 $86,000

Others Institutions Holding GILD

# of Institutions

1,941

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.

Account

Bsw Wealth Partners Gilead Sciences, Inc. Transaction History